Following the results of the UK’s referendum on 23 June, the life sciences industry needs to prepare for the impact of a change in the relationship between the UK and EU. The impact will differ from company to company, but it is possible to shed light on the extent, the timing and who in the industry will be affected, by considering the different activities in the industry value chain and the role of European rules and regulation. To read more, click the link below.
100 days. 14 executive orders. Some bold healthcare policies.
In this CRA Insights, we assess the actions and impact of the second Trump Administration during the first 100 days that directly affect healthcare policy,...